MedTrace Logo

Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder

NCT00004834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2013-02-21

No results posted yet for this study

Summary

OBJECTIVES:

I. Determine which treatment is most effective for patients with panic disorder: cognitive-behavioral therapy (CBT) plus imipramine (IMI), CBT plus placebo, CBT alone, IMI alone, or placebo alone.

Conditions

  • Panic Disorder

Interventions

DRUG

imipramine

BEHAVIORAL

cognitive-behavioral therapy

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Long Island Jewish Medical Center

    collaborator OTHER

  • Northwell Health

    lead OTHER

Principal Investigators

  • Jack M. Gorman · Long Island Jewish Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-05-31
Primary Completion
2005-06-30
Completion
2005-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004834 on ClinicalTrials.gov